A detailed history of Us Bancorp \De\ transactions in Alector, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 22,953 shares of ALEC stock, worth $101,222. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,953
Previous 6,218 269.14%
Holding current value
$101,222
Previous $49,000 181.63%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$5.69 - $8.08 $95,222 - $135,218
16,735 Added 269.14%
22,953 $138,000
Q4 2023

Feb 09, 2024

BUY
$3.77 - $8.39 $15,950 - $35,498
4,231 Added 212.93%
6,218 $49,000
Q3 2023

Nov 03, 2023

SELL
$5.2 - $8.77 $187 - $315
-36 Reduced 1.78%
1,987 $12,000
Q2 2023

Aug 09, 2023

BUY
$5.86 - $7.93 $3,211 - $4,345
548 Added 37.15%
2,023 $12,000
Q4 2022

Feb 13, 2023

SELL
$6.88 - $9.55 $1,486 - $2,062
-216 Reduced 12.77%
1,475 $13,000
Q3 2022

Oct 27, 2022

BUY
$8.19 - $13.2 $1,220 - $1,966
149 Added 9.66%
1,691 $16,000
Q2 2022

Aug 01, 2022

BUY
$7.65 - $14.24 $2,455 - $4,571
321 Added 26.29%
1,542 $16,000
Q1 2022

May 11, 2022

BUY
$13.02 - $20.78 $2,643 - $4,218
203 Added 19.94%
1,221 $18,000
Q4 2021

Feb 11, 2022

SELL
$19.35 - $25.54 $14,860 - $19,614
-768 Reduced 43.0%
1,018 $21,000
Q3 2021

Nov 10, 2021

SELL
$21.65 - $39.49 $3,940 - $7,187
-182 Reduced 9.25%
1,786 $41,000
Q1 2021

Apr 28, 2021

BUY
$14.84 - $22.23 $11,872 - $17,784
800 Added 68.49%
1,968 $40,000
Q4 2020

Feb 04, 2021

SELL
$9.4 - $16.7 $5,940 - $10,554
-632 Reduced 35.11%
1,168 $18,000
Q3 2020

Nov 10, 2020

SELL
$10.54 - $24.96 $11,341 - $26,856
-1,076 Reduced 37.41%
1,800 $19,000
Q2 2020

Aug 07, 2020

BUY
$21.87 - $33.11 $1,662 - $2,516
76 Added 2.71%
2,876 $70,000
Q1 2020

May 13, 2020

BUY
$16.25 - $35.28 $37,375 - $81,144
2,300 Added 460.0%
2,800 $68,000
Q4 2019

Feb 04, 2020

BUY
$14.17 - $20.3 $3,542 - $5,075
250 Added 100.0%
500 $9,000
Q3 2019

Nov 08, 2019

BUY
$14.42 - $22.2 $3,605 - $5,550
250 New
250 $4,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $364M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.